| Tag | Content |
|---|
EnhancerAtlas ID | HS184-15502 |
Organism | Homo sapiens |
Tissue/cell | T47D |
Coordinate | chr19:38553560-38554400 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr19:38553832-38553853 | TCCCCTCCACCCCCCTCCCCA | - | 6.35 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_10857 | chr19:38548064-38555238 | CD20 | | SE_33570 | chr19:38547726-38556155 | H2171 | | SE_61973 | chr19:38519548-38571581 | Toledo | | SE_63333 | chr19:38548346-38569687 | NCI-H82 | | SE_65256 | chr19:38551210-38555782 | Pancreatic_islets | | SE_66973 | chr19:38547726-38556155 | H2171 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I038062 | chr19 | 38553425 | 38555011 |
|
Enhancer Sequence | GATGTTCTCA AATGGGGTGG CCCCATGAGT TGTCACGAGG GCAGACTCGA GTCAGCCAAT 60
CCCAGGTTCA GATTCCGGCT CCTCCTCCCC TTCTCTTTGT GGCCCTCTCT GAACCCCATT 120
GTGAAGCACG GGTGACAGTA GCAGGTGATT AGAAGCTTCA GTGCAATGGT TTGTGTTATG 180
GTGTCATGTG CTCTGCACAG GGCCTGGCTC CCCGACAGCC CTGGGTCAGG GGCCAGTTAG 240
GATGATGGAT GATTACTGCC AGCAGCTGGG TTTCCCCTCC ACCCCCCTCC CCACTCCAAC 300
CTGGATAACA AGGCCCAGCT GTGTGTGTCC AGCACCTGCA CCGCCCCCGC CGGCCCCCAG 360
CTCCCATCCC TGCCAGCCTT CCCACGGCAG GGAGCCTTCC TGGCTGTGGT GTTCCGGGTG 420
GGCCCCACTG CCGCCCCCCA TCCCCTCAGC CTAGAGCCAT CCTCAGGTTA GGATAAGCAG 480
AGCCGGAGCC ACCCTCAGCC CGGCCCCCAG CGGCAGGATG GAAAGAGTGG GACTTTAACA 540
GATGTTCTTT TACAAGGATT CCCTGGCTCT ATTTAATCAA GATTGTCGAA TATTGATTTA 600
ATCTCCAGGC CCAACAGATG CGGTCTTAGC AGGTTTCAGT GGCAATTAGC TGGGATCAGT 660
TTGCAGGTCA GGCTCCGTGC TGGCAAGACA CTGTCTTCTA AAGGAGGCTT GGCCTGGCCA 720
CAGGAGTGAG CCCTGGAGGA GGGCGCGTAC TAAGTATTTA ACCATCAGTC TAGCCCGGGC 780
AGTGGCCCAC GGGAGCAGGC CCGCAGGCTG GGTCATAGCA GCCCCTGTGG GGCCCCAGTG 840
|
